NDC 70954-592 – Tezruly

Terazosin Hydrochloride 1 mg/mL · Solution · Oral

Human Prescription Drug

Product NDC70954-592

Product details

Brand name
Tezruly
Generic name
Terazosin
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
Solution
Route
Oral
Marketing category
NDA · NDA218139
Marketed since
April 18, 2025
Listing expires
December 31, 2026
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Tezruly →

Package NDC codes (1)

Package NDCDescriptionSince
70954-592-10150 mL in 1 BOTTLE (70954-592-10)Apr 18, 2025